Skip to content

Comment on The Villain of CRISPRparent

Comments

The Broad Institute has given an exclusive license to a commercial entity (Editas Medicine) for certain uses of CRISPR. I don't imagine UC would behave any differently.

AboutSource Built by g1lg1l

Hackerly is an independent reader for Hacker News, built on the public HN API. Not affiliated with Y Combinator.